Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor global drug patents, generic suppliers and generics

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cipla	ABACAVIR SULFATE AND LAMIVUDINE	abacavir sulfate; lamivudine	TABLET;ORAL	091144-001	Mar 28, 2017	AB	RX	No	No	Start Trial	Start Trial				Start Trial
Lupin Ltd	ABACAVIR SULFATE AND LAMIVUDINE	abacavir sulfate; lamivudine	TABLET;ORAL	204990-001	Mar 28, 2017	AB	RX	No	No	Start Trial	Start Trial				Start Trial
Zydus Pharms	ABACAVIR SULFATE AND LAMIVUDINE	abacavir sulfate; lamivudine	TABLET;ORAL	208990-001	Nov 15, 2018		DISCN	No	No	Start Trial	Start Trial				Start Trial
Teva Pharms Usa	ABACAVIR SULFATE AND LAMIVUDINE	abacavir sulfate; lamivudine	TABLET;ORAL	079246-001	Sep 29, 2016	AB	RX	No	No	Start Trial	Start Trial				Start Trial
Aurobindo Pharma Ltd	ABACAVIR SULFATE AND LAMIVUDINE	abacavir sulfate; lamivudine	TABLET;ORAL	206151-001	Mar 28, 2017	AB	RX	No	No	Start Trial	Start Trial				Start Trial
Aurobindo Pharma Ltd	ABACAVIR SULFATE AND LAMIVUDINE	abacavir sulfate; lamivudine	TABLET;ORAL	090159-001	Nov 15, 2018	AB	RX	No	No	Start Trial	Start Trial				Start Trial
Lupin Ltd	ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE	abacavir sulfate; lamivudine; zidovudine	TABLET;ORAL	202912-001	Dec 5, 2013	AB	RX	No	No	Start Trial	Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor Drug Class List